These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1825562)

  • 1. A novel method for the analysis of PAF and alkyl-ether phospholipids by mass spectrometry.
    Balazy M; Cluzel J; Bazan NG
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():323-6. PubMed ID: 1825562
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
    Balazy M; Braquet P; Bazan NG
    Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
    Shindo K; Hashimoto Y
    Drugs Exp Clin Res; 1991; 17(7):343-9. PubMed ID: 1794300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of platelet-activating factor in biological samples by high resolution mass spectrometry.
    Magni F; Berti F; De Angelis L; Rossoni G; Galli G
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():327-30. PubMed ID: 1825563
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry.
    Savu SR; Silvestro L; Sörgel F; Montrucchio G; Lupia E; Camussi G
    J Chromatogr B Biomed Appl; 1996 Jun; 682(1):35-45. PubMed ID: 8832423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel steroid-modified ether phospholipids.
    Karantonis HC; Pitsinos EN; Antonopoulou S; Couladouros EA; Demopoulos CA
    Chem Phys Lipids; 2005 Dec; 138(1-2):12-9. PubMed ID: 16202400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry.
    Christman BW; Blair IA
    Biomed Environ Mass Spectrom; 1989 Apr; 18(4):258-64. PubMed ID: 2706378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of alkyl and alkenyl ether-linked phospholipids and platelet-activating factor-like lipid in various species of invertebrates.
    Sugiura T; Fukuda T; Miyamoto T; Waku K
    Biochim Biophys Acta; 1992 Jun; 1126(3):298-308. PubMed ID: 1637858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of platelet activating factor and related ether lipids: enzymatic pathways, subcellular sites, regulation, and membrane processing.
    Snyder F
    Prog Clin Biol Res; 1988; 282():57-72. PubMed ID: 3071807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry.
    Haroldsen PE; Gaskell SJ
    Biomed Environ Mass Spectrom; 1989 Jun; 18(6):439-44. PubMed ID: 2504312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor.
    Owen JS; Thomas MJ; Wykle RL
    Methods Enzymol; 2007; 434():105-16. PubMed ID: 17954244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.
    Oda M; Satouchi K; Yasunaga K; Saito K
    J Immunol; 1985 Feb; 134(2):1090-3. PubMed ID: 3917470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of lyso-platelet activating factor by negative ion gas chromatography/mass spectrometry of the nitrobenzal acetal derivatives.
    Mallet AI
    Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):207-10. PubMed ID: 3242671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
    Ramesha CS; Pickett WC
    J Immunol; 1987 Mar; 138(5):1559-63. PubMed ID: 3100641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular heterogeneity of PAF in normal human mixed saliva: quantitative mass spectral analysis after direct derivatization of PAF with pentafluorobenzoic anhydride.
    Woodard DS; Mealey BL; Lear CS; Satsangi RK; Prihoda TJ; Weintraub ST; Pinckard RN; McManus LM
    Biochim Biophys Acta; 1995 Nov; 1259(2):137-47. PubMed ID: 7488633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.
    Turk J; Bohrer A; Stump WT; Ramanadham S; Mangino MJ
    J Chromatogr; 1992 Mar; 575(2):183-96. PubMed ID: 1629294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of MK-287, a new platelet-activating factor antagonist, in plasma and serum by gas chromatography chemical ionization mass spectrometry.
    Fisher AL; Morris MJ; Gilbert JD
    Biol Mass Spectrom; 1991 Jul; 20(7):408-14. PubMed ID: 1932155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions.
    Furukawa M; Kubo N; Yamashita T
    Laryngoscope; 1995 Feb; 105(2):188-91. PubMed ID: 8544602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor and its structural analogues in the earthworm Eisenia foetida.
    Sugiura T; Yamashita A; Kudo N; Fukuda T; Miyamoto T; Cheng NN; Kishimoto S; Waku K; Tanaka T; Tsukatani H
    Biochim Biophys Acta; 1995 Aug; 1258(1):19-26. PubMed ID: 7654776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of phosphono analogs of a phospholipid platelet activating factor].
    Chuvilin AN; Trusov VG; Serebrennikova GA
    Bioorg Khim; 1992 Jun; 18(6):862-70. PubMed ID: 1418000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.